Predictors of survival in systemic sclerosis (scleroderma).
暂无分享,去创建一个
D. Bloch | R. Altman | T. Medsger | B. Michel | Daniel A. Bloch | Roy D. Altman | Beat A. Michel | Thomas A. Medsger
[1] M R Segal,et al. A comparison of estimated proportional hazards models and regression trees. , 1989, Statistics in medicine.
[2] A. Silman,et al. An epidemiological study of scleroderma in the West Midlands. , 1988, British journal of rheumatology.
[3] S. Jimenez,et al. Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients. , 1988, Seminars in arthritis and rheumatism.
[4] A. Masi,et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. , 1988, The American journal of medicine.
[5] Mark R. Segal,et al. Regression Trees for Censored Data , 1988 .
[6] T. Medsger,et al. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. , 1988, Arthritis and rheumatism.
[7] G. Littlejohn,et al. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. , 1988, The Journal of rheumatology.
[8] E. Hurd,et al. Scleroderma and scleroderma-like disorders. , 1986, Seminars in arthritis and rheumatism.
[9] N. Fineberg,et al. Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. , 1985, American heart journal.
[10] Neuberger Js,et al. Epidemiology of the rheumatic diseases. , 1984 .
[11] M. Hochberg,et al. Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. , 1984, The American journal of medicine.
[12] J. Rice,et al. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants. , 1983, Arthritis and rheumatism.
[13] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[14] E. Tan,et al. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. , 1980, Arthritis and rheumatism.
[15] A. Masi,et al. The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. , 1978, Journal of chronic diseases.
[16] N. Rowell. The prognosis of systemic sclerosis , 1974 .
[17] A. Masi,et al. Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. , 1973, Journal of chronic diseases.
[18] P. Holt,et al. Survival in scleroderma. , 1971, Annals of the rheumatic diseases.
[19] A. Masi,et al. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. , 1971, Annals of internal medicine.
[20] A. Masi,et al. Epidemiology of systemic sclerosis (scleroderma). , 1971, Annals of internal medicine.
[21] A. Masi,et al. Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore. , 1967, Annals of internal medicine.
[22] R. Winkelmann,et al. Diffuse systemic scleroderma. A comparison with acrosclerosis. , 1962, Annals of internal medicine.
[23] R. Winkelmann,et al. Systemic scleroderma, A clinical study of 727 cases. , 1961, Archives of dermatology.
[24] E. Hines,et al. Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic Scleroderma: A Study of 271 Cases , 1960, Circulation.